NGS and personalized medicine: The role of data interpretation
The advance of Next Generation Sequencing (NGS) technology has enabled researchers to generate genome wide data in unprecedented quality and quantity. Genomatix offers solutions and services for the entire course of analysis from first level mapping to integrating multiple results with copious high-quality data background. Our technologies for visualization and interpretation enable scientists world-wide to turn their data into meaningful results, making NGS the perfect vehicle to enable personalized medicine
Dr. Martin Seifert, CSO of Genomatix will give a presentation at Oxford Global's NGS Congress in London, UK on November 18th-19th, 2013.
|The Genomatix Pathway System (GePS) is now available in Illumina's BaseSpace Apps.||Genomatix is among the partners of the European RADIANT research project on rapid development and distribution of statistical tools for high-throughput sequencing data.|
|» read more on the meeting webpage||» read more in our press release||» read more on the project webpage|